KNBIF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
5.49M
MMIRF
Price
$0.01
Change
-$0.02 (-66.67%)
Updated
Jun 4 closing price
Capitalization
41.03M
Interact to see
Advertisement

KNBIF vs MMIRF

Header iconKNBIF vs MMIRF Comparison
Open Charts KNBIF vs MMIRFBanner chart's image
Kane Biotech
Price$0.04
Change-$0.00 (-0.00%)
Volume$2.2K
Capitalization5.49M
Medmira
Price$0.01
Change-$0.02 (-66.67%)
Volume$234
Capitalization41.03M
KNBIF vs MMIRF Comparison Chart
Loading...
View a ticker or compare two or three
VS
KNBIF vs. MMIRF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNBIF is a Hold and MMIRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (KNBIF: $0.04 vs. MMIRF: $0.01)
Brand notoriety: KNBIF and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNBIF: 3% vs. MMIRF: 25%
Market capitalization -- KNBIF: $5.49M vs. MMIRF: $41.03M
KNBIF [@Biotechnology] is valued at $5.49M. MMIRF’s [@Biotechnology] market capitalization is $41.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNBIF’s FA Score shows that 0 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • KNBIF’s FA Score: 0 green, 5 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, both KNBIF and MMIRF are a bad buy in the long-term.

Price Growth

KNBIF (@Biotechnology) experienced а +3.34% price change this week, while MMIRF (@Biotechnology) price change was -54.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

MMIRF is expected to report earnings on Apr 02, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
MMIRF($41M) has a higher market cap than KNBIF($5.49M). MMIRF YTD gains are higher at: 6.870 vs. KNBIF (-51.818). MMIRF has higher annual earnings (EBITDA): -3.13M vs. KNBIF (-3.94M). KNBIF has more cash in the bank: 544K vs. MMIRF (296K). KNBIF has less debt than MMIRF: KNBIF (2.28M) vs MMIRF (9.49M). KNBIF has higher revenues than MMIRF: KNBIF (2.01M) vs MMIRF (277K).
KNBIFMMIRFKNBIF / MMIRF
Capitalization5.49M41M13%
EBITDA-3.94M-3.13M126%
Gain YTD-51.8186.870-754%
P/E Ratio1.07N/A-
Revenue2.01M277K727%
Total Cash544K296K184%
Total Debt2.28M9.49M24%
FUNDAMENTALS RATINGS
KNBIF vs MMIRF: Fundamental Ratings
KNBIF
MMIRF
OUTLOOK RATING
1..100
8598
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9597
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (4) in the null industry is in the same range as KNBIF (34). This means that MMIRF’s stock grew similarly to KNBIF’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as KNBIF (100). This means that MMIRF’s stock grew similarly to KNBIF’s over the last 12 months.

MMIRF's SMR Rating (100) in the null industry is in the same range as KNBIF (100). This means that MMIRF’s stock grew similarly to KNBIF’s over the last 12 months.

KNBIF's Price Growth Rating (95) in the null industry is in the same range as MMIRF (97). This means that KNBIF’s stock grew similarly to MMIRF’s over the last 12 months.

KNBIF's P/E Growth Rating (93) in the null industry is in the same range as MMIRF (100). This means that KNBIF’s stock grew similarly to MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CDEI72.531.21
+1.70%
Calvert US Large-Cp Div, Eq AndIncETF
SPSM41.970.45
+1.08%
SPDR® Portfolio S&P 600™ Sm Cap ETF
SLVO80.620.37
+0.47%
UBS ETRACS Silver Shares Covered CallETN
ENFR31.880.11
+0.35%
Alerian Energy Infrastructure ETF
FLDR49.99-0.01
-0.03%
Fidelity Low Duration Bond Factor ETF

KNBIF and

Correlation & Price change

A.I.dvisor tells us that KNBIF and CADL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNBIF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNBIF
1D Price
Change %
KNBIF100%
N/A
CADL - KNBIF
22%
Poorly correlated
+8.83%
LQDA - KNBIF
21%
Poorly correlated
+0.67%
SPHDF - KNBIF
20%
Poorly correlated
N/A
MMIRF - KNBIF
12%
Poorly correlated
N/A
IGXT - KNBIF
7%
Poorly correlated
N/A
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+1.77%
AZTR - MMIRF
24%
Poorly correlated
+0.22%
SRPT - MMIRF
22%
Poorly correlated
+9.69%
SAGE - MMIRF
22%
Poorly correlated
+1.03%
More